The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44)

被引:245
作者
De Maria, A
Fogli, M
Costa, P
Murdaca, G
Puppo, F
Mavilio, D
Moretta, A
Moretta, L
机构
[1] Univ Genoa, Dipartimento Med Interna, I-16132 Genoa, Italy
[2] Univ Genoa, Dipartimento Med Sperimentale, Genoa, Italy
[3] Ctr Eccellenza Ric Biomed, Genoa, Italy
[4] Ist Sci G Gaslini, Genoa, Italy
关键词
NK cell; natural cytotoxicity receptor; ART; HIV-1;
D O I
10.1002/eji.200324141
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Signals leading to NK cell triggering are primarily mediated by natural cytotoxicity receptors (NCR) upon binding to as-yet-undefined cell surface ligand(s) on normal hematopoietic cells, pathogen-infected cells or tumor cells. In this study we tried to determine whether the decreased NK cell cytolytic function that is observed in HIV-1-infected patients may be related to a decreased expression of NCR. In HIV-1-infected patients, freshly drawn, purified NK cells expressed significantly decreased surface densities of NKp46 and NKp30 NCR. The low surface density of NKp46, NKp30 and NKp44 was also confirmed in in-vitro-activated NK cell populations and NK cell clones derived from HIV-1 patients compared with uninfected donors. This defective NCR expression in HIV-1 patients was associated with a parallel decrease of NCR-mediated killing of different tumor target cells. Thus, the present study indicates that the defective expression of NCR represents at least one of the possible mechanisms leading to the impaired NK cell function in HIV-1 infection and it can contribute to explain the relatively high frequency of opportunistic tumors reported in cohorts of untreated patients before the occurrence of profound immunosuppression (<200 CD4(+) cells/mm(3)).
引用
收藏
页码:2410 / 2418
页数:9
相关论文
共 42 条
  • [1] Modulation of expression of the MHC class I-binding natural killer cell receptors, and NK activity in relation to viral load in HIV-infected/AIDS patients
    Ahmad, R
    Sindhu, STAK
    Tran, P
    Toma, E
    Morisset, R
    Menezes, J
    Ahmad, A
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2001, 65 (03) : 431 - 440
  • [2] Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation
    Asai, O
    Longo, DL
    Tian, ZG
    Hornung, RL
    Taub, DD
    Ruscetti, FW
    Murphy, WJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (09) : 1835 - 1842
  • [3] Natural killer cells in antiviral defense: Function and regulation by innate cytokines
    Biron, CA
    Nguyen, KB
    Pien, GC
    Cousens, LP
    Salazar-Mather, TP
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 : 189 - 220
  • [4] BONAVIDA B, 1986, J IMMUNOL, V137, P1157
  • [5] BRENNER BG, 1993, CLIN EXP IMMUNOL, V93, P142
  • [6] CAI Q, 1990, J ACQ IMMUN DEF SYND, V3, P669
  • [7] Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors:: Consequences for the NK-mediated killing of dendritic cells
    Castriconi, R
    Cantoni, C
    Della Chiesa, M
    Vitale, M
    Marcenaro, E
    Conte, R
    Biassoni, R
    Bottino, C
    Moretta, L
    Moretta, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) : 4120 - 4125
  • [8] Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia
    Costello, RT
    Sivori, S
    Marcenaro, E
    Lafage-Pochitaloff, M
    Mozziconacci, MJ
    Reviron, D
    Gastaut, JA
    Pende, D
    Olive, D
    Moretta, A
    [J]. BLOOD, 2002, 99 (10) : 3661 - 3667
  • [9] De Maria A, 2001, EUR J IMMUNOL, V31, P3546, DOI 10.1002/1521-4141(200112)31:12<3546::AID-IMMU3546>3.0.CO
  • [10] 2-W